Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wellmune WGP reduces ragweed allergy symptoms: Biothera
The placebo-controlled, double-blinded study equally divided 48 healthy subjects (31 female, 17 male; 39 ± 13 years of age) into two groups. One group consumed a placebo while
The placebo-controlled, double-blinded study equally divided 48 healthy subjects (31 female, 17 male; 39 ± 13 years of age) into two groups. One group consumed a placebo while
Alemtuzumab is a humanized monoclonal antibody used as a potential therapy to treat relapsing-remitting multiple sclerosis. In the trial, alemtuzumab was given to patients in two or three
reaZin, formerly named Zinthionein, is a proprietary, gastroretentive, sustained release, once-daily oral tablet formulated from zinc (150 mg) and cysteine (100 mg), an amino acid with potent anti-oxidant
Lapatinib is an oral small-molecule inhibitor of the EGFR and ErbB2 (HER2) tyrosine kinase receptors. The company seeks the approval for Tyverb as a treatment for the patients
Hyalofemme is a proprietary gel formulation of hyaluronate, a naturally occurring polysaccharide with moisturising and lubricating properties. Hyalofemme has been shown to be effective when used 3 times
The fingerprint technology discerns the so-called forensic ‘fingerprint’ of herbal medicine components using advanced techniques including chromatographic or spectral profiling. The profile can be used to identify different
Developed by Takeda, Edarbi is an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension to lower blood pressure in adults. Edarbi may be used either
Modufolin (6R-5,10-methylenetetrahydrofolate) is a novel folate-based drug developed to increase the efficacy and reduce the side effects of antimetabolites used in cancer treatment. However, Eli Lilly’s Alimta is
Sativex is an endocannabinoid modulator made of two actives – THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol). It was developed and is manufactured by GW Pharmaceuticals. GW Pharmaceuticals’ marketing partner
The company’s decision is based on an interim analysis data, which according to the members of the Interim Review Committee does not support the continuation of GLPG0259’s development